ShorterE.A History of psychiatry: From the era of the asylum to the age of Prozac. Toronto (ON): John Wiley & Sons; 1998.
2.
HonigfeldGGillisRDKlettCJ. Nurses' Observation Scale for Inpatient Evaluation: A new scale for measuring improvement in chronic schizophrenia. J Clin Psychol. 1965;21:65–71.
3.
SwayzeVW2nd. Frontal leukotomy and related psychosurgical procedures in the era before antipsychotics (1935–1954): A historical overview. Am J Psychiatry. 1995;152(4):505–515.
MenningerW.Psychiatry in a troubled world. New York (NY): MacMillan; 1948.
6.
GoffmanE.Asylums. Essays on the social situation of mental patients and other inmates. New York (NY): Doubleday Anchor; 1961.
7.
WhiteMCChafetzLCollins-BrideG, History of arrest, incarceration and victimization in community-based severely mentally ill. J Community Health. 2006;31(2):123–135.
8.
EttnerSLFrankRKesslerRC. The impact of psychiatric disorders on labor market outcomes. Industrial and Labor Relations Review. 1997;51(1):64–81.
9.
MittalDDavisCEDeppC, Correlates of health-related quality of well-being in older patients with schizophrenia. J Nerv Ment Dis. 2006;194(5):335–340.
10.
LiebermanJAStroupTSMcEvoyJP, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–1223.
11.
DrewLR. Mortality and mental illness. Aust N Z J Psychiatry. 2005;39(3):194–197.
12.
FilikRSiposAKehoePG, The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand. 2006;113(4):298–305.
13.
GoffDCSullivanLMMcEvoyJP, A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80(1):45–53.
14.
DaumitGLPronovostPJAnthonyCB, Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry. 2006;63(3):267–272.
15.
BrownSInskipHBarracloughB.Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212–217.
16.
HennekensCHHennekensARHollarD, Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(5):1115–1121.
17.
RasanenSHakkoHViiloK, Excess mortality among long-stay psychiatric patients in Northern Finland. Soc Psychiatry Psychiatr Epidemiol. 2003;38(6):297–304.
18.
PriorPHassallCCrossKW. Causes of death associated with psychiatric illness. J Public Health Med. 1996;18(4):381–389.
19.
SakuMTokudomeSIkedaM, Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol. 1995;24(2):366–372.
20.
WalshEMoranPScottC, Prevalence of violent victimisation in severe mental illness. Br J Psychiatry. 2003;183:233–238.
21.
HiroehUApplebyLMortensenPB, Death by homicide, suicide, and other unnatural causes in people with mental illness: A population-based study. Lancet. 2001;358(9299):2110–2112.
22.
HealyDHarrisMTranterR, Lifetime suicide rates in treated schizophrenia: 1875–1924 and 1994–1998 cohorts compared. Br J Psychiatry. 2006;188:223–228.
23.
LawrenceDJablenskyAVHolmanCD, Mortality in Western Australian psychiatric patients. Soc Psychiatry Psychiatr Epidemiol. 2000;35(8):341–347.
24.
AmaddeoFBisoffiGBonizzatoP, Mortality among patients with psychiatric illness. A ten-year case register study in an area with a community-based system of care. Br J Psychiatry. 1995;166:783–788.
25.
HansenVJacobsenBKArnesenE.Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry. 2001;179:438–443.
26.
LermanPApgarDHJordanT.Deinstitutionalization and mortality: Findings of a controlled research design in New Jersey. Ment Retard. 2003;41(4):225–236.
HibbsJRBennerLKlugmanL, Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med. 1994;331(5):304–309.
29.
BabidgeNCBuhrichNButlerT.Mortality among homeless people with schizophrenia in Sydney, Australia: A 10-year follow-up. Acta Psychiatr Scand. 2001;103(2):105–110.
30.
HeilaHHaukkaJSuvisaariJ, Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med. 2005;35(5):725–732.
31.
SalokangasRKHonkonenTStengardE, Mortality in chronic schizophrenia during decreasing number of psychiatric beds in Finland. Schizophr Res. 2002;54(3):265–275.
32.
BraletMCYonVLoasGNoisetteC.Cause of mortality in schizophrenic patients: Prospective study of years of a cohort of 150 chronic schizophrenic patients]Encephale. 2000;26(6):32–41.
33.
DemblingBPChenDTVachonL.Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv. 1999;50(8):1036–1042.
34.
JoukamaaMHeliovaaraMKnektP, Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry. 2006;188:122–127.
35.
SaariKKoponenHLaitinenJ, Hyperlipidemia in persons using antipsychotic medication: A general population-based birth cohort study. J Clin Psychiatry. 2004;65(4):547–550.
36.
OsbornDPNazarethIKingMB. Risk for coronary heart disease in people with severe mental illness: Cross-sectional comparative study in primary care. Br J Psychiatry. 2006;188:271–277.
37.
HaggSLindblomYMjorndalT, High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. Int Clin Psychopharmacol. 2006;21(2):93–8.
38.
SchneiderLSDagermanKSInselP.Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934–1943.
39.
WangPSSchneeweissSAvornJ, Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353(22):2335–2341.
BasuAMeltzerHY. Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era. Schizophr Res. 2006;86(1–3):99–109.
42.
NewcomerJW. Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs. 2005;19(Suppl 1):1–93.
43.
SernyakMJGulanskiBRosenheckR.Undiagnosed hyperglycemia in patients treated with atypical antipsychotics. J Clin Psychiatry. 2005;66(11):1463–1467.
44.
RayWAMeredithSThapaPB, Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58(12):1161–1167.
45.
StrausSMSturkenboomMCBleuminkGS, Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005;26(17):2007–2012.
46.
MartinMA. The homeless mentally ill and community-based care: Changing a mindset. Community Ment Health J. 1990;26(5):435–447.
47.
DoornbosMM. Family caregivers and the mental health care system: Reality and dreams. Arch Psychiatr Nurs. 2002;16(1):39–46.
48.
SmithGC. Patterns and predictors of service use and unmet needs among aging families of adults with severe mental illness. Psychiatr Serv. 2003;54(6):871–877.
49.
PiatMRicardNLesageA, Le point de vue des responsables des ressources de type familial sur les transformations des services de santé mentale au Québec. Santé Mentale Québec. 2005;30:209–231.
50.
BayerRFairchildAL. The genesis of public health ethics. Bioethics. 2004;18(6):473–492.
51.
GrossML. Autonomy and paternalism in communitarian society. Patient rights in Israel. Hastings Cent Rep. 1999;29(4):13–20.
52.
LoewyEH. In defense of paternalism. Theor Med Bioeth. 2005;26(6):445–468.